MD•benzinga•
Looking Into Mednax's Return On Capital Employed
Summary
Mednax (NYSE:MD) brought in sales totaling $482.23 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 144.61%, resulting in a loss of $21.19 million.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 2, 2022 by benzinga